Investors

Enanta Pharmaceuticals is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field.

Recent News

More News >>

Upcoming Events
There are currently no events scheduled.

More Events >>

Stock Quote
ENTA (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$33.39
Change (%) Stock is Up 0.26 (0.78%)
Volume266,164
Data as of 04/17/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Email Alerts

Sign up to receive email alerts whenever Enanta Pharmaceuticals Inc posts new information to the site.

Just enter your email address and click Submit.
 
Investor Relations Contact
Carol Miceli
Director, Investor Relations
Enanta Pharmaceuticals, Inc.
Phone: 617-607-0710
Email: cmiceli@enanta.com

Media Relations Contact
Kari Watson
MacDougall Biomedical Communications
Phone: 781-235-3060
Email: kwatson@macbiocom.com

 ;